DENDREON GETS ORPHAN DRUG STATUS FROM FDA FOR MYLOVENGE.: An article from: Biotech Business
Book Details
Publisher
Worldwide Videotex
ISBN / ASIN
B0008FAEGW
ISBN-13
978B0008FAEG8
Availability
Available for download now
Sales Rank
#99,999,999
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Biotech Business, published by Worldwide Videotex on June 1, 2002. The length of the article is 5079 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: DENDREON GETS ORPHAN DRUG STATUS FROM FDA FOR MYLOVENGE.
Publication:Biotech Business (Newsletter)
Date: June 1, 2002
Publisher: Worldwide Videotex
Volume: 15 Issue: 6 Page: NA
Distributed by Thomson Gale
Citation Details
Title: DENDREON GETS ORPHAN DRUG STATUS FROM FDA FOR MYLOVENGE.
Publication:Biotech Business (Newsletter)
Date: June 1, 2002
Publisher: Worldwide Videotex
Volume: 15 Issue: 6 Page: NA
Distributed by Thomson Gale
